Post-transfusion-transmitted hepatitis C virus infection: A study on thalassemia and hemodialysis patients in southeastern Iran

Archives of Virology

Volumn 156, Issue 7, 2011, Pages 1111-1115

  Hassanshahi, Gholamhossein ^a   Arababadi, Mohammad Kazemi ^a   Assar, Shokrollah ^a   Hakimi, Hamid ^a   karimabad, Mozhgan Noroozi ^a   Abedinzadeh, Mehdi ^a   Rafatpanah, Houshang ^b   Derakhshan, Reza ^a  

^a RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CHILD; CROSS-SECTIONAL STUDY; DISEASE TRANSMISSION; FEMALE; GENETICS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IRAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; PHYSIOLOGY; PRESCHOOL CHILD; RENAL REPLACEMENT THERAPY; THALASSEMIA; VIROLOGY;

ADOLESCENT; ADULT; AGED; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; IRAN; MALE; MIDDLE AGED; RENAL DIALYSIS; THALASSEMIA; YOUNG ADULT;

HEPATITIS C VIRUS;

EID: 79959608117     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-011-0950-y     Document Type: Article

References (19)

1. Chuma M, Hige S, Nakanishi M, Ogawa K, Natsuizaka M, Yamamoto Y et al (2008) 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol 23(9): 1431-1436.
2. Eissa SA, Abdel Meguid LM, Ebeid SM, Abou Elfetouh RM, Abdel Moneim GM (2007) National Cancer Institute experience in healthy Egyptian blood donors as regards blood group frequencies and seroprevalence of hepatitis b virus, hepatitis C Virus & HIV: 10 year evaluation. J Egypt Natl Cancer Inst 19(1): 71-76.
3. Chakrabarti S, Pradhan P, Roy A, Hira M, Bandyopadhyay G, Bhattacharya DK (2006) Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products. Indian J Public Health 50(1): 43-44.
4. Mirmomen S, Alavian SM, Hajarizadeh B, Kafaee J, Yektaparast B, Zahedi MJ et al (2006) Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infections in patients with beta-thalassemia in Iran: a multicenter study. Arch Iran Med 9(4): 319-323.
5. Vermehren J, Kau A, Gartner BC, Gobel R, Zeuzem S, Sarrazin C (2008) Differences between two real-time PCR-based hepatitis C virus (HCV) assays (RealTime HCV and Cobas AmpliPrep/Cobas TaqMan) and one signal amplification assay (Versant HCV RNA 3. 0) for RNA detection and quantification. J Clin Microbiol 46(12): 3880-3891.
6. Samavat A, Modell B (2004) Iranian national thalassaemia screening programme. BMJ 329(7475): 1134-1137.
7. Arnold C, Allison S, Aamra D (2004) Lessons from thalassaemia screening in Iran Screening programmes must consider societal. BMJ 329(7475): 1115-1117.
8. Fallah MS, Samavat A, Zeinali S (2009) Iranian national program for the prevention of thalassemia and prenatal diagnosis: mandatory premarital screening and legal medical abortion. Prenat Diagn 29(13): 1285-1286.
9. Saxena AK, Panhotra BR, Sundaram DS, Naguib M, Venkateshappa CK, Uzzaman W et al (2003) Impact of dedicated space, dialysis equipment, and nursing staff on the transmission of hepatitis C virus in a hemodialysis unit of the middle east. Am J Infect Control 31(1): 26-33.
10. Lemos LB, Perez RM, Matos CA, Silva IS, Silva AE, Ferraz ML (2008) Clinical and laboratory characteristics of acute hepatitis C in patients with end-stage renal disease on hemodialysis. J Clin Gastroenterol 42(2): 208-211.
11. Martin P, Fabrizi F (2008) Hepatitis C virus and kidney disease. J Hepatology 49(4): 613-624.
12. Fissell RB, Bragg-Gresham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA et al (2004) Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 65(6): 2335-2342.
13. Laosombat V, Pornpatkul M, Wongchanchailert M, Worachat K, Wiriyasatienku A (1997) The prevalence of hepatitis C virus antibodies in thalassemic patients in the south of Thailand. Southeast Asian J Trop Med Public Health 28(1): 149-153.
14. Ansar MM, Kooloobandi A (2002) Prevalence of hepatitis C virus infection in thalassemia and haemodialysis patients in north Iran-Rasht. J Viral Hepat 9(5): 390-392.
15. Chakravarti A, Verma V, Kumaria R, Dubey AP (2005) Anti-HCV seropositivity among multiple transfused patients with beta thalassaemia. J Indian Med Assoc 103(2): 64-66.
16. Huraib S, al-Rashed R, Aldrees A, Aljefry M, Arif M, al-Faleh FA (1995) High prevalence of and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia: a need for new dialysis strategies. Nephrol Dial Transpl 10(4): 470-474.
17. Cadranel JF, Di Martino V, Lambrey G, Mourlhon C, Nalet B, Anciaux ML et al (2008) Prevalence of hepatitis C infection and risk factors in hospitalized diabetic patients: results of a cross-sectional study. Eur J Gastroenterol Hepatol 20(9): 829-836.
18. Kasraeian L, Tavasoli A (2008) Prevalence of hepatitic C and its factors in blood donors at Shiraz transfusion center. koomesh fall 10(1): 7-12.
19. Delavari M, Tabatabaei SM (2004) Frequency of hepatitis C and its related factors in blood donors in Kerman 2003. Journal of Army University Medical Sciences of Iran (JAUMS) 2(2): 323-358.